Provided by Tiger Fintech (Singapore) Pte. Ltd.

Meihua International Medical Technologies

0.2903
-0.0047-1.59%
Volume:37.57K
Turnover:10.98K
Market Cap:9.26M
PE:0.79
High:0.3099
Open:0.2871
Low:0.2771
Close:0.2950
Loading ...
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Apr 24, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 23, 2024

Correspondence

Form CORRESP - Correspondence
Feb 23, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Feb 21, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Feb 06, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Sep 29, 2023

Correspondence

Form CORRESP - Correspondence
Sep 26, 2023

Correspondence

Form CORRESP - Correspondence
Aug 29, 2023

Correspondence

Form CORRESP - Correspondence
Aug 29, 2023

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Aug 22, 2023

Correspondence

Form CORRESP - Correspondence
Aug 21, 2023

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Jul 04, 2023

Correspondence

Form CORRESP - Correspondence
Jul 03, 2023

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Apr 14, 2023

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jul 29, 2022

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Correspondence

Form CORRESP - Correspondence
Feb 14, 2022

Correspondence

Form CORRESP - Correspondence
Feb 08, 2022

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Feb 08, 2022

Correspondence

Form CORRESP - Correspondence